Citigroup Inc Absci Corp Transaction History
Citigroup Inc
- $217 Billion
- Q3 2025
A detailed history of Citigroup Inc transactions in Absci Corp stock. As of the latest transaction made, Citigroup Inc holds 21,658 shares of ABSI stock, worth $61,941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,658
Previous 40,933
47.09%
Holding current value
$61,941
Previous $105,000
38.1%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ABSI
# of Institutions
153Shares Held
70.2MCall Options Held
701KPut Options Held
541K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.2MShares$34.8 Million0.26% of portfolio
-
Redmile Group, LLC San Francisco, CA8.25MShares$23.6 Million2.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.28MShares$20.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$15.3 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.19MShares$9.13 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $266M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....